Concepedia

Author

David Bante

Universität InnsbruckORCID

Also Known As

Bante, David, Bianca Neurauter, David Bante, the HEVACC Study Group

25

Publications

518

Citations

10

H-Index

13

Concepts

All Affiliations

Universität InnsbruckInnsbruck Medical UniversityUniversity of CambridgeHoward Hughes Medical InstituteKing Abdullah University of Science and Technology
DB

About

David Bante is an author at Universität Innsbruck specializing in viral immunity, vaccination, and humoral immunity.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

101

2

Immunology

2

2

101

3

Humoral Immunity

2

2

101

4

Pathology

1

1

11

5

Autoimmunity

1

1

11

David Bante

×

9

Publications

444

Citations

9

H-Index

YearCitations

SARS-CoV-2 3CL <sup>pro</sup> mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376

Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi,

Science Translational Medicine

2022

131

SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals

Annika Rössler, Lydia Riepler, David Bante,

2021

90

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants

Annika Rössler, Antonia Netzl, Ludwig Knabl,

Nature Communications

2022

88

Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography

Annika Rössler, Antonia Netzl, Ludwig Knabl,

Nature Communications

2023

43

Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial

Zoltán Bánki, José Mateus, Annika Rössler,

EBioMedicine

2022

38

Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial

Lisa Seekircher, Zoltán Bánki, Janine Kimpel,

The Lancet Microbe

2023

20

Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir

Laura Krismer, Helge Schöppe, Stefanie Rauch,

npj Viruses

2024

13

BA.2 omicron differs immunologically from both BA.1 omicron and pre-omicron variants

Annika Rössler, Antonia Netzl, Ludwig Knabl,

2022

11

A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system

Francesco Costacurta, Andrea Dodaro, David Bante,

PLoS Pathogens

2024

10

Page 1